Canada Gazette, Part I, Volume 153, Number 16: Order Amending Schedule I to the Controlled Drugs and Substances Act (Tramadol)
April 20, 2019
Controlled Drugs and Substances Act
Department of Health
REGULATORY IMPACT ANALYSIS STATEMENT
For the Regulatory Impact Analysis Statement, see the Regulations Amending the Narcotic Control Regulations (Tramadol).
PROPOSED REGULATORY TEXT
Notice is given that the Governor in Council, pursuant to section 60 footnote a of the Controlled Drugs and Substances Act footnote b, considering that it is necessary in the public interest, proposes to make the annexed Order Amending Schedule I to the Controlled Drugs and Substances Act (Tramadol).
Interested persons may make representations concerning the proposed Order within 60 days after the date of publication of this notice. All such representations must cite the Canada Gazette, Part I, and the date of publication of this notice, and be addressed to the Office of Legislative and Regulatory Affairs, Controlled Substances Directorate, Healthy Environments and Consumer Safety Branch, Department of Health, Address Locator: 0302A, 150 Tunney’s Pasture Driveway, Ottawa, Ontario K1A 0K9 (email: firstname.lastname@example.org).
Ottawa, April 11, 2019
Assistant Clerk of the Privy Council
Order Amending Schedule I to the Controlled Drugs and Substances Act (Tramadol)
1 Schedule I to the Controlled Drugs and Substances Act footnote 1 is amended by adding the following after item 26:
- 27 Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol), its salts, isomers and salts of isomers and the following derivatives of tramadol and the salts, isomers and salts of isomers of these derivatives:
- (1) O-desmethyltramadol (3-[2[(dimethylamino)methyl]-1-hydroxycyclohexyl]-phenol)
- (2) N,O-didesmethyltramadol (3-[1-hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol)
Coming into Force
2 This Order comes into force on the first anniversary of the day on which it is published in the Canada Gazette, Part II.